Translate Bio, Inc. is an early-clinical-stage biotechnology company developing mRNA therapeutics and vaccines targeting protein or gene dysfunction and infectious diseases respectively. Translate Bio ...

Bio Equity Risk Management has formed as a Boston-based investment firm focused on special situations opportunities in the healthcare industry. The firm’s co-founding managing partners are Nessan ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) today announced key management and board appointments in advance of the company’s planned separation, targeted for mid-October, ...

Punishment of both Bio-Rad Laboratories, Inc. and Sartorius AG continued throughout the final stages of 2022. Bio-Rad Laboratories had an equally challenging Q3, setting up Q4 and FY22 numbers as key ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T ...

Mabwell (Shanghai) Bioscience Co. Ltd. and Aditum Bio Management Company LLC have announced the launch of Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to ...

Propel Bio Partners is a leading global venture fund specializing in life science investments, offering a comprehensive ecosystem of experts to empower entrepreneurs to realize their visions. Richard ...